Information for the public

Avelumab is a possible treatment for metastatic (secondary) Merkel cell carcinoma in adults.

  • For people who have had chemotherapy, avelumab is available on the NHS.
  • For people who have not had chemotherapy, avelumab is available through the Cancer Drugs Fund. More evidence on the drug is being collected, until May 2019. NICE will then decide whether or not to recommend it for use in the NHS, for people who have not had chemotherapy. It will be available through the Cancer Drugs Fund until then.

Is this treatment right for me?

Your healthcare professionals should give you clear information, talk with you about your options and listen carefully to your views and concerns. Your family can be involved too, if you wish. Read more about making decisions about your care.

Questions to think about

  • How well does it work compared with other treatments?
  • What are the risks or side effects? How likely are they?
  • How will the treatment affect my day-to-day life?
  • What happens if the treatment does not work?
  • What happens if I do not want to have treatment? Are there other treatments available?

Information and support

NHS Choices may be a good place to find out more.

These organisations can give you advice and support:

You can also get support from your local Healthwatch.

NICE is not responsible for the quality or accuracy of any information or advice provided by these organisations.

ISBN: 978-1-4731-2925-2


This page was last updated: 11 April 2018